Omori, T.; Sasaki, Y.; Koroku, M.; Murasugi, S.; Yonezawa, M.; Nakamura, S.; Tokushige, K.
Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn’s Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy. J. Clin. Med. 2022, 11, 2494.
https://doi.org/10.3390/jcm11092494
AMA Style
Omori T, Sasaki Y, Koroku M, Murasugi S, Yonezawa M, Nakamura S, Tokushige K.
Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn’s Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy. Journal of Clinical Medicine. 2022; 11(9):2494.
https://doi.org/10.3390/jcm11092494
Chicago/Turabian Style
Omori, Teppei, Yu Sasaki, Miki Koroku, Shun Murasugi, Maria Yonezawa, Shinichi Nakamura, and Katsutoshi Tokushige.
2022. "Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn’s Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy" Journal of Clinical Medicine 11, no. 9: 2494.
https://doi.org/10.3390/jcm11092494
APA Style
Omori, T., Sasaki, Y., Koroku, M., Murasugi, S., Yonezawa, M., Nakamura, S., & Tokushige, K.
(2022). Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn’s Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy. Journal of Clinical Medicine, 11(9), 2494.
https://doi.org/10.3390/jcm11092494